Search
Showing results for " https://www.galaxus.ch/en/sector/showdiscussion/snaphack-iphone-visit-kunghaccom-nssr1r3i-224165"
There is growing evidence to support partial oral antibiotic treatment of severe infections such as Staphylococcus aureus bacteremia, but clinical practice is slow to adopt this paradigm. We know little about how patients with severe infection experience and perceive intravenous and oral antibiotics in terms of quality of life and clinical effectiveness. We performed a qualitative study to elicit patients' views on treatment with intravenous and oral antibiotics, aiming to provide insights that could inform collaborative treatment decision-making.
ENDIA (Environmental Determinants of Islet Autoimmunity) is a national observational study into the causes of Type 1 Diabetes in childhood.
This is your chance to play a vital role in shaping Australia's COVID-19 vaccine program
A decade long partnership with Wesfarmers Ltd. and the Wesfarmers Centre of Vaccines and Infectious Diseases has led to world-class paediatric research and important collaborations fuelling the Centre’s trajectory towards easing the burden of infectious diseases.
Diabetes researchers from The Kids Research Institute Australia and Perth Children’s Hospital are excited to be taking part in the national Insulin
Off-label antipsychotic prescribing for non-psychotic disorders is increasing, often at low doses and over extended periods. While cardiometabolic adverse effects are documented among individuals treated with antipsychotics for psychotic disorders, the consequences of long-term off-label antipsychotic use are not well-known.
Did you catch the kids’ takeover Telethon segment on the weekend? If so, you may have spied James Fernihough hanging out with Ch 7 television personality Andrew Denton in the The Kids Discovery Centre.
See the most recent C3 news.
In this blog, Senior Speech Pathologist Sally Grauaug and Speech Pathology Clinical Lead Aria May discuss the use of visual supports.
ENVISAGE is a free peer support program specifically designed for parents and caregivers of children aged 0-8 years with disabilities or developmental concerns. Term 3 dates now released.